Évaluation de la sécurité de l’embolisation par LipiodolⓇ dans l’arthrose digitale symptomatique réfractaire au traitement conventionnel : étude pilote sur 15 patients

2024-513361-40-00 Human pharmacology (Phase I) - Bioequivalence study Ongoing, recruiting

Start 5 Dec 2024 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Bioequivalence study
Status Ongoing, recruiting
Participants planned 15
Countries 1
Sites 1

Arthrose digitale répondant aux critères de classification de l’American College of Rheumatology (ACR), touchant au moins deux articulations interphalangiennes proximales (IPP) et/ou distales (IPD) présentant un stade radiologique de Kellgren-Lawrence (KL) ≥ 2 et symptomatique dans les 3 derniers mois.

Key facts

Sponsor
Centre Hospitalier Universitaire Grenoble Alpes
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Musculoskeletal Diseases [C05]
Trial duration
5 Dec 2024 → ongoing
Decision date (initial)
2024-07-15
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Arthrose digitale répondant aux critères de classification de l’American College of Rheumatology (ACR), touchant au moins deux articulations interphalangiennes proximales (IPP) et/ou distales (IPD) présentant un stade radiologique de Kellgren-Lawrence (KL) ≥ 2 et symptomatique dans les 3 derniers mois.

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Centre Hospitalier Universitaire Grenoble Alpes

Sponsor organisation
Centre Hospitalier Universitaire Grenoble Alpes
Address
Av De Kimberley, Bp 185 Bp 185
City
Echirolles
Postcode
38130
Country
France

Scientific contact point

Organisation
Centre Hospitalier Universitaire Grenoble Alpes
Contact name
Dr Xavier ROMAND

Public contact point

Organisation
Centre Hospitalier Universitaire Grenoble Alpes
Contact name
Dr Xavier ROMAND

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
France Ongoing, recruiting 15 1
Rest of world 0

Investigational sites

France

1 site · Ongoing, recruiting
Centre Hospitalier Universitaire Grenoble Alpes
Rhumatology, Av De Kimberley, Bp 185, Echirolles

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
France 2024-12-05 2025-01-30

Application history

2 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-04-15 France Acceptable
2024-07-15
2024-07-15
2 SUBSTANTIAL MODIFICATION SM-1 2026-02-05 France Acceptable
2026-03-11
2026-03-11